Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy

Journal of Urology

Volumn 189, Issue 3, 2013, Pages 849-853

  Schroeck, Florian R ^a   Zuhlke, Kimberly A ^a,b   Siddiqui, Javed ^a   Siddiqui, Rabia ^a   Cooney, Kathleen A ^a,b   Wei, John T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

biopsy; germ line mutation; prostate; prostatic neoplasms

Indexed keywords

ADULT; ANALYZER; ARTICLE; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; GENE; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HOXB13 GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOPSY; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERM-LINE MUTATION; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84873736252     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.09.117     Document Type: Article

References (23)

1. K.W. Jasperson, T.M. Tuohy, D.W. Neklason Hereditary and familial colon cancer Gastroenterology 138 2010 2044
2. A. Antoniou, P.D. Pharoah, S. Narod Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 2003 1117
3. A. Tutt, A. Ashworth Can genetic testing guide treatment in breast cancer? Eur J Cancer 44 2008 2774
4. K.L. Nathanson, S.M. Domchek Therapeutic approaches for women predisposed to breast cancer Ann Rev Med 62 2011 295
5. W.J. Langeberg, W.B. Isaacs, J.L. Stanford Genetic etiology of hereditary prostate cancer Front Biosci 12 2007 4101
6. S.L. Zheng, J. Sun, F. Wiklund Cumulative association of five genetic variants with prostate cancer N Engl J Med 358 2008 910
7. C.A. Salinas, J.S. Koopmeiners, E.M. Kwon Clinical utility of five genetic variants for predicting prostate cancer risk and mortality Prostate 69 2009 363
8. S. Lindström, F.R. Schumacher, D. Cox Common genetic variants in prostate cancer risk prediction-results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) Cancer Epidemiol Biomarkers Prev 21 2012 437
9. C.M. Ewing, A.M. Ray, E.M. Lange Germline mutations in HOXB13 and prostate-cancer risk N Engl J Med 366 2012 141
10. C. Jung, R.S. Kim, H.J. Zhang HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling Cancer Res 64 2004 9185
11. J.D. Norris, C.Y. Chang, B.M. Wittmann The homeodomain protein HOXB13 regulates the cellular response to androgens Mol Cell 36 2009 405
12. D.W. Bruner, D. Moore, A. Parlanti Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis Int J Cancer 107 2003 797
13. L.E. Johns, R.S. Houlston A systematic review and meta-analysis of familial prostate cancer risk BJU Int 91 2003 789
14. M. Kiciński, J. Vangronsveld, T.S. Nawrot An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis PLoS One 6 2011 e27130
15. I.M. Thompson, D.P. Ankerst, C. Chi Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 2006 529
16. O.M. Zaytoun, M.W. Kattan, A.S. Moussa Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information Urology 78 2011 392
17. R.K. Nam, M.W. Kattan, J.L. Chin Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators J Clin Oncol 29 2011 2959
18. S.B. Gabriel, S.F. Schaffner, H. Nguyen The structure of haplotype blocks in the human genome Science 296 2002 2225
19. C.J. Clopper, E.S. Pearson The use of confidence or fiducial limits illustrated in the case of the binomial Biometrika 26 1934 404
20. A. Li-Wan-Po, P. Farndon, C. Cooley When is a genetic test suitable for prime time? Predicting the risk of prostate cancer as a case-example Public Health Genomics 13 2010 55
21. S.A. Tomlins, A. Bjartell, A.M. Chinnaiyan ETS gene fusions in prostate cancer: from discovery to daily clinical practice Eur Urol 56 2009 275
22. S.A. Tomlins, S.M. Aubin, J. Siddiqui Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA Sci Transl Med 3 2011 94ra72
23. J.H. Park, M.H. Gail, M.H. Greene Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers J Clin Oncol 30 2012 2157